Among all the predicted genes in Figure 2A, SOCS1 43, MYBL2 44, ITGB3 45, FOXD1 46 have been reported to be involved in the progression, metastasis or drug resistance in breast cancer. This evidence concerns the gene ITGB3 and breast cancer.